Journal Article Summary
The article investigates how ethanol and estradiol, a form of estrogen, affect the release of prolactin (PRL) from the pituitary gland. This topic is significant because elevated levels of prolactin have been observed in individuals with alcohol use disorders, and understanding the mechanisms behind this increase can help in managing related health issues. The study aims to clarify how these substances influence the splicing of dopamine D2 receptor messenger RNA, which plays a role in regulating PRL release.
In this study, researchers used Fischer-344 rats and primary cultures of anterior pituitary cells to examine the effects of ethanol and estradiol on PRL mRNA levels and dopamine D2 receptor splicing. They found that both substances increased PRL mRNA expression and altered the splicing of the D2 receptor, leading to a higher proportion of the long form (D2L) and a lower proportion of the short form (D2S). Additionally, ethanol was shown to diminish the effectiveness of bromocriptine, a drug that typically inhibits PRL release, indicating that ethanol interferes with dopamine's ability to regulate PRL levels.
The study has some limitations, including its focus on animal models, which may not fully represent human physiology. Patients should be aware that the interaction between alcohol, estrogen, and prolactin can have implications for health, particularly in those with alcohol use disorders. It is advisable for readers to discuss these findings with a healthcare professional, especially if they have concerns about hormone levels or alcohol consumption, to better understand their individual health context and any potential risks.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Oomizu Souichi, Boyadjieva Nadka, Sarkar Dipak K.. Ethanol and Estradiol Modulate Alternative Splicing of Dopamine D2 Receptor Messenger RNA and Abolish the Inhibitory Action of Bromocriptine on Prolactin Release From the Pituitary Gland. Alcoholism, clinical and experimental research 2003. DOI: 10.1097/01.ALC.0000071743.57855.BE. PMID: 12824819. PMCID: PMC2869286.
Featured Pill Pals Product
Estradiol (Estrogen) Transdermal System Patch 0.0375 MG/DAY --- 4 PACK --- Generic for Climara --- Mylan Pharma
Estradiol Transdermal System Patch 0.0375 MG/DAY --- 4 PACK --- Generic for Vivelle Dot and Minivelle --- Mylan Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
